📖

Microglia

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-cell-types-microglia
Related Entities
cell-types-microglia
Metadata
slugcell-types-microglia
entity_typecell
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (692)
mentions🧪Temporal Decoupling via Circadian Clock Reset65%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination65%
mentions🧪Netrin-1 Gradient Restoration65%
mentions🧪Smartphone-Detected Motor Variability Correction65%
mentions🧪Purinergic Signaling Polarization Control65%
mentions🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 65%
mentions🧪Circadian-Synchronized Proteostasis Enhancement65%
mentions🧪HSP90-Tau Disaggregation Complex Enhancement65%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer65%
mentions🧪Mitochondrial SPM Synthesis Platform Engineering65%
mentions🧪VCP-Mediated Autophagy Enhancement65%
mentions🧪Senescent Cell Mitochondrial DNA Release65%
mentions🧪SASP-Mediated Cholinergic Synapse Disruption65%
mentions🧪Multi-Modal Stress Response Harmonization65%
mentions🧪Complement C1q Mimetic Decoy Therapy65%
mentions🧪CYP46A1 Overexpression Gene Therapy65%
mentions🧪Enteric Nervous System Prion-Like Propagation Blockade65%
mentions🧪Retinal Vascular Microcirculation Rescue65%
mentions🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition65%
mentions🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho65%
mentions🧪Metabolic Circuit Breaker via Lipid Droplet Modulation65%
mentions🧪Noradrenergic-Tau Propagation Blockade65%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones65%
mentions🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists65%
mentions🧪Biorhythmic Interference via Controlled Sleep Oscillations65%
mentions🧪SIRT6-NAD+ Axis Enhancement Therapy65%
mentions🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics65%
mentions🧪Circadian Rhythm Entrainment of Reactive Astrocytes65%
mentions🧪SASP-Mediated Complement Cascade Amplification65%
mentions🧪Complement C1q Subtype Switching65%
mentions🧪Microglial Purinergic Reprogramming65%
mentions🧪Heat Shock Protein 70 Disaggregase Amplification65%
mentions🧪Autophagosome Maturation Checkpoint Control65%
mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener65%
mentions🧪Prefrontal sensory gating circuit restoration via PV interne65%
mentions🧪PARP1 Inhibition Therapy65%
mentions🧪Ocular Immune Privilege Extension65%
mentions🧪Extracellular Matrix Stiffness Modulation65%
mentions🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism65%
mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor65%
mentions🧪Senescence-Induced Lipid Peroxidation Spreading65%
mentions🧪Piezoelectric Nanochannel BBB Disruption65%
mentions🧪Lipid Droplet Dynamics as Phenotype Switches65%
mentions🧪Glycine-Rich Domain Competitive Inhibition65%
mentions🧪SASP-Driven Aquaporin-4 Dysregulation65%
mentions🧪Circadian-Gated Maresin Biosynthesis Amplification65%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna65%
mentions🧪Orexin-Microglia Modulation Therapy65%
mentions🧪Blood-Brain Barrier SPM Shuttle System65%
mentions🧪Stress Granule Phase Separation Modulators65%
mentions🧪TFAM overexpression creates mitochondrial donor-recipient gr65%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction65%
mentions🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto65%
mentions🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu65%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy65%
mentions🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati65%
mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th65%
mentions🧪TREM2-mediated microglial tau clearance enhancement65%
mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides65%
mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri65%
mentions🧪Senescence-Associated Myelin Lipid Remodeling65%
mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy65%
mentions🧪R-Loop Resolution Enhancement Therapy65%
mentions🧪Senescence-Activated NAD+ Depletion Rescue65%
mentions🧪Epigenetic Memory Erasure via TET2 Activation65%
mentions🧪Selective Acid Sphingomyelinase Modulation Therapy65%
mentions🧪Vocal Cord Neuroplasticity Stimulation65%
mentions🧪Synthetic Biology Rewiring via Orthogonal Receptors65%
mentions🧪Ephrin-B2/EphB4 Axis Manipulation65%
mentions🧪Microbial Inflammasome Priming Prevention65%
mentions🧪Phase-Separated Organelle Targeting65%
mentions🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution65%
mentions🧪Purinergic P2Y12 Inverse Agonist Therapy65%
mentions🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection65%
mentions🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat65%
mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming65%
mentions🧪Trans-Synaptic Adhesion Molecule Modulation65%
mentions🧪RNA Granule Nucleation Site Modulation65%
mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia65%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation65%
mentions🧪Complement C1QA Spatial Gradient in Cortical Layers65%
mentions🧪APOE Isoform Expression Across Glial Subtypes65%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR60%
mentions🔬What are the mechanisms underlying microglia-astrocyte cross60%
mentions🔬What are the mechanisms underlying synaptic pruning by micro60%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR60%
mentions🔬Extracellular vesicle biomarkers for early AD detection60%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen60%
mentions🔬Analyze the spectrum of microglial activation states (DAM, h60%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise60%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc60%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc60%
mentions🔬Which cell types show the most significant expression change60%
mentions🔬Immune atlas neuroinflammation analysis in neurodegeneration60%
mentions🔬Cell type vulnerability in Alzheimer's Disease (SEA-AD 60%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc60%
mentions🔬Neuroinflammation and microglial priming in early Alzheimer&60%
mentions🔬Neuroinflammation and microglial priming in early Alzheimer&60%
mentions🔬Neuroinflammation and microglial priming in early AD — Analy60%
mentions🔬Senescent cell clearance as neurodegeneration therapy60%
mentions🔬Which specific metabolic pathways in APOE4+ microglia are mo60%
mentions🔬Can P16INK4A expression reliably distinguish harmful from be60%
mentions🧫SPP1-mediated microglial synaptic engulfment assay60%
mentions🧫Neuroimmune modulation and Aβ clearance mechanisms60%
mentions🧫C1q neutralization experiment60%
mentions🧫LPS-induced mouse model of depression with synaptic loss ana60%
mentions🧫Microglial depletion study using clodronate liposomes60%
mentions🧫Sevoflurane-induced neurotoxicity (SIN) model in rats60%
mentions🧫Cell type-specific P2rx7 deletion in microglia vs astrocytes60%
mentions🧫Longitudinal TLR2 reporter gene study in α-synuclein mice60%
mentions🧫CB2R deletion effects on GVHD-induced behavioral changes60%
mentions🧫C1q neutralizing antibody intervention in depression model60%
mentions🧫PH-PS treatment in 5×FAD Alzheimer's disease mice60%
mentions🧫SIRPα modulation in mouse models of Alzheimer's disease60%
mentions🧫In vivo IGF-I intravitreal injection in rd10 mice60%
mentions🧫Analysis of IBA1 low/negative microglia in liver disease pat60%
mentions🧫Butyrate treatment on microglial cytokine expression in aged60%
mentions🧫Cell-cell interaction analysis of perivascular-microglial cr60%
mentions🧫Rab27a knockdown effects on microglia activation in developi60%
mentions🧫Adoptive transfer of TCRAβ-Tregs in AD mouse model60%
mentions🧫Chi3l1 deletion in APP/PS1 mouse model of Alzheimer's d60%
mentions🧫High fiber diet effects on gut microbiome and neuroinflammat60%
mentions🧫Single-cell RNA sequencing of microglial states in AD hippoc60%
mentions🧫bEV-mediated synaptic pruning via C1q-C3 pathway60%
mentions🧫BDEV injection and recipient microglial transcriptome analys60%
mentions🧫Characterization of astrocyte-derived EVs and microglia upta60%
mentions🧫Sevoflurane-induced neurotoxicity (SIN) rat model60%
mentions🧫Microglia-specific SIRPα deletion in conditional knockout mi60%
mentions🧫Single-cell RNA sequencing analysis of microglial heterogene60%
mentions🧫Chi3l1 deletion effects on baseline glial activation in mice60%
mentions🧫Dexamethasone treatment study in α-synuclein mice60%
mentions🧫Small RNA profiling of neonatal astrocyte EVs and microglia 60%
mentions🧫Ex vivo IGF-I treatment in rd10 organotypic retinal explants60%
mentions🧫Proposed experiment from debate on Astrocytes adopt A1 (neur60%
mentions🧫s:** - ALOX15 overexpression in healthy astrocytes should be60%
mentions🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional60%
mentions🧫s:** - Single-cell RNA-seq to measure editing efficiency acr60%
mentions🧫s:** - Dose-response studies showing therapeutic window with60%
mentions🧫Morphological characterization of microglial states in human60%
mentions🧫Microglial SIRPα expression in human Alzheimer's diseas60%
mentions🧫Single-cell RNA sequencing of mouse brains60%
mentions🧫Microglial activation by bEVs via Piezo160%
mentions🧫Microglial depletion rescue experiment60%
mentions🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal60%
mentions🧫4R-Tau Targeting Therapies for PSP and CBS60%
mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi60%
mentions🧫Computational Modeling of Alpha-Synuclein Propagation in PD60%
mentions🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti60%
mentions🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?60%
mentions🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy60%
mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri60%
mentions🧫ApoE4 Function in Alzheimer's Disease60%
mentions🧫Experiment: Autoimmune Hypothesis Testing in AD60%
mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring60%
mentions🧫Brainstem Circuit Modulation for PSP60%
mentions🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi60%
mentions🧫cGAS-STING Pathway Validation Study in Parkinson's Dise60%
mentions🧫Combination Therapy Sequencing in Parkinson's Disease60%
mentions🧫DLB Cognitive Fluctuation Mechanism Experiment60%
mentions🧫Genetic Risk Modifiers in DLB Phenotype60%
mentions🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras60%
mentions🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i60%
mentions🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 60%
mentions🧫Endocannabinoid System Dysfunction Validation in Parkinson&#60%
mentions🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M60%
mentions🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation60%
mentions🧫Gap Junction Dysfunction Validation in Parkinson's Dise60%
mentions🧫Iron Dyshomeostasis in MSA Pathogenesis Experiment60%
mentions🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown60%
mentions🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design60%
mentions🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise60%
mentions🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr60%
mentions🧫Microglial Contributions to Huntington's Disease Pathog60%
mentions🧫Mixed Pathology Effects on Parkinson's Disease Progress60%
mentions🧫Neural Stem Cell Therapy for Alzheimer's Disease60%
mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise60%
mentions🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper60%
mentions🧫Progranulin Replacement Therapy for FTD — Vector Development60%
mentions🧫PSP and CBS Biomarker Validation Study60%
mentions🧫Purinergic Signaling Dysfunction Validation in Parkinson60%
mentions🧫Regulated Necrosis Validation Study in Parkinson's Dise60%
mentions🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease60%
mentions🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#60%
mentions🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo60%
mentions🧫Tau Spreading Network Mapping via Spatial Transcriptomics in60%
mentions🧫Traumatic Brain Injury and Alzheimer's Disease Relation60%
mentions🧫Experiment Validation: In vitro ThT Assay60%
mentions🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an60%
mentions🧫Tau ASO Therapy60%
mentions🧫Microglial TREM2 Agonist In Vivo Efficacy60%
mentions🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim60%
mentions🧫TREM2 Function in Alzheimer's Disease — From Risk Varia60%
see_also📖Hypothalamus60%
see_also📖ABCA1 - ATP-Binding Cassette Transporter A160%
see_also📖Abelson Helper Integration Site 160%
see_also📖CLEC7A Gene60%
see_also📖EGR460%
see_also📖GSK3A Gene60%
see_also📖IL12A — Interleukin-12 Alpha60%
see_also📖IL1RL1 Gene60%
see_also📖nfatc260%
see_also📖PQBP1 Gene - Polyglutamine Binding Protein 160%
see_also📖SCRIB Gene60%
see_also📖SPG11 Gene - Spastic Paraplegia 1160%
see_also📖TLR6 Gene60%
see_also📖iPSC-Derived Dopaminergic Neurons60%
see_also📖ABCA7 (Redirect)60%
see_also📖adam1060%
see_also📖CTSB Gene60%
see_also📖DDX1 Gene60%
see_also📖MYT1L Gene60%
see_also📖p2ry260%
see_also📖RPL24 — Ribosomal Protein L2460%
see_also📖RPS23 — Ribosomal Protein S2360%
see_also📖Accelerating Medicines Partnership for Alzheimer's Dise60%
see_also📖mGluR1 Protein60%
see_also📖mGluR5 Protein60%
see_also📖GALC Gene60%
see_also📖HGSNAT Gene60%
see_also📖DLB Cognitive Fluctuation Mechanism Experiment60%
see_also📖DYSF — Dysferlin60%
see_also📖syna60%
see_also📖il1rn60%
see_also📖LRP1060%
see_also📖SESN3 Gene60%
see_also📖CNS Drug Delivery Methods60%
see_also📖ACTB Gene60%
see_also📖EPHB3 Gene60%
see_also📖SLC18A2 Gene60%
see_also📖SASP (Senescence-Associated Secretory Phenotype) in Neurodeg60%
see_also📖KMT2B — lysine methyltransferase 2B60%
see_also📖NFKB2 Gene60%
see_also📖SEC22B Gene60%
see_also📖STX3 Gene60%
see_also📖VGLUT2 Gene60%
see_also📖OXR1 — Oxidoreductase NRD160%
see_also📖SYT6 (Synaptotagmin 6)60%
related🧪Temporal Decoupling via Circadian Clock Reset58%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination58%
related🧪Netrin-1 Gradient Restoration58%
related🧪Smartphone-Detected Motor Variability Correction58%
related🧪Purinergic Signaling Polarization Control58%
related🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 58%
related🧪Circadian-Synchronized Proteostasis Enhancement58%
related🧪HSP90-Tau Disaggregation Complex Enhancement58%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer58%
related🧪Mitochondrial SPM Synthesis Platform Engineering58%
related🧪VCP-Mediated Autophagy Enhancement58%
related🧪Senescent Cell Mitochondrial DNA Release58%
related🧪SASP-Mediated Cholinergic Synapse Disruption58%
related🧪Multi-Modal Stress Response Harmonization58%
related🧪Complement C1q Mimetic Decoy Therapy58%
related🧪CYP46A1 Overexpression Gene Therapy58%
related🧪Enteric Nervous System Prion-Like Propagation Blockade58%
related🧪Retinal Vascular Microcirculation Rescue58%
related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition58%
related🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho58%
related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation58%
related🧪Noradrenergic-Tau Propagation Blockade58%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones58%
related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists58%
related🧪Biorhythmic Interference via Controlled Sleep Oscillations58%
related🧪SIRT6-NAD+ Axis Enhancement Therapy58%
related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics58%
related🧪Circadian Rhythm Entrainment of Reactive Astrocytes58%
related🧪SASP-Mediated Complement Cascade Amplification58%
related🧪Complement C1q Subtype Switching58%
related🧪Microglial Purinergic Reprogramming58%
related🧪Heat Shock Protein 70 Disaggregase Amplification58%
related🧪Autophagosome Maturation Checkpoint Control58%
related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener58%
related🧪Prefrontal sensory gating circuit restoration via PV interne58%
related🧪PARP1 Inhibition Therapy58%
related🧪Ocular Immune Privilege Extension58%
related🧪Extracellular Matrix Stiffness Modulation58%
related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism58%
related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor58%
related🧪Senescence-Induced Lipid Peroxidation Spreading58%
related🧪Piezoelectric Nanochannel BBB Disruption58%
related🧪Lipid Droplet Dynamics as Phenotype Switches58%
related🧪Glycine-Rich Domain Competitive Inhibition58%
related🧪SASP-Driven Aquaporin-4 Dysregulation58%
related🧪Circadian-Gated Maresin Biosynthesis Amplification58%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna58%
related🧪Orexin-Microglia Modulation Therapy58%
related🧪Blood-Brain Barrier SPM Shuttle System58%
related🧪Stress Granule Phase Separation Modulators58%
related🧪TFAM overexpression creates mitochondrial donor-recipient gr58%
related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction58%
related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto58%
related🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu58%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy58%
related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati58%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th58%
related🧪TREM2-mediated microglial tau clearance enhancement58%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides58%
related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri58%
related🧪Senescence-Associated Myelin Lipid Remodeling58%
related🧪Gamma entrainment therapy to restore hippocampal-cortical sy58%
related🧪R-Loop Resolution Enhancement Therapy58%
related🧪Senescence-Activated NAD+ Depletion Rescue58%
related🧪Epigenetic Memory Erasure via TET2 Activation58%
related🧪Selective Acid Sphingomyelinase Modulation Therapy58%
related🧪Vocal Cord Neuroplasticity Stimulation58%
related🧪Synthetic Biology Rewiring via Orthogonal Receptors58%
related🧪Ephrin-B2/EphB4 Axis Manipulation58%
related🧪Microbial Inflammasome Priming Prevention58%
related🧪Phase-Separated Organelle Targeting58%
related🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution58%
related🧪Purinergic P2Y12 Inverse Agonist Therapy58%
related🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection58%
related🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat58%
related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming58%
related🧪Trans-Synaptic Adhesion Molecule Modulation58%
related🧪RNA Granule Nucleation Site Modulation58%
related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition55%
related🧪Targeted Butyrate Supplementation for Microglial Phenotype M55%
related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists55%
related🧪Microglial Purinergic Reprogramming55%
related🧪TREM2-Dependent Microglial Senescence Transition55%
related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor55%
related🧪Orexin-Microglia Modulation Therapy55%
related🧪TREM2-mediated microglial tau clearance enhancement55%
related🧪Microglia-Derived Extracellular Vesicle Engineering for Targ55%
related🧪Adenosine-Astrocyte Metabolic Reset55%
related🧪Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro55%
related🧪Circadian-Gated Maresin Biosynthesis Amplification55%
related🧪Mitochondrial SPM Synthesis Platform Engineering55%
related🔬The disease-associated microglia (DAM) phenotype involves TR54%
related🔬What are the mechanisms underlying microglia-astrocyte cross54%
related🔬What are the mechanisms underlying synaptic pruning by micro54%
related🔬The disease-associated microglia (DAM) phenotype involves TR54%
related🔬Extracellular vesicle biomarkers for early AD detection54%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen54%
related🔬Analyze the spectrum of microglial activation states (DAM, h54%
related🔬What cell types are most vulnerable in Alzheimer's Dise54%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc54%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc54%
related🔬Which cell types show the most significant expression change54%
related🔬Immune atlas neuroinflammation analysis in neurodegeneration54%
related🔬Cell type vulnerability in Alzheimer's Disease (SEA-AD 54%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc54%
related🔬Neuroinflammation and microglial priming in early Alzheimer&54%
related🔬Neuroinflammation and microglial priming in early Alzheimer&54%
related🔬Neuroinflammation and microglial priming in early AD — Analy54%
related🔬Senescent cell clearance as neurodegeneration therapy54%
related🔬Which specific metabolic pathways in APOE4+ microglia are mo54%
related🔬Can P16INK4A expression reliably distinguish harmful from be54%
related🧫SPP1-mediated microglial synaptic engulfment assay54%
related🧫Neuroimmune modulation and Aβ clearance mechanisms54%
related🧫C1q neutralization experiment54%
related🧫LPS-induced mouse model of depression with synaptic loss ana54%
related🧫Microglial depletion study using clodronate liposomes54%
related🧫Sevoflurane-induced neurotoxicity (SIN) model in rats54%
related🧫Cell type-specific P2rx7 deletion in microglia vs astrocytes54%
related🧫Longitudinal TLR2 reporter gene study in α-synuclein mice54%
related🧫CB2R deletion effects on GVHD-induced behavioral changes54%
related🧫C1q neutralizing antibody intervention in depression model54%
related🧫PH-PS treatment in 5×FAD Alzheimer's disease mice54%
related🧫SIRPα modulation in mouse models of Alzheimer's disease54%
related🧫In vivo IGF-I intravitreal injection in rd10 mice54%
related🧫Analysis of IBA1 low/negative microglia in liver disease pat54%
related🧫Butyrate treatment on microglial cytokine expression in aged54%
related🧫Cell-cell interaction analysis of perivascular-microglial cr54%
related🧫Rab27a knockdown effects on microglia activation in developi54%
related🧫Adoptive transfer of TCRAβ-Tregs in AD mouse model54%
related🧫Chi3l1 deletion in APP/PS1 mouse model of Alzheimer's d54%
related🧫High fiber diet effects on gut microbiome and neuroinflammat54%
related🧫Single-cell RNA sequencing of microglial states in AD hippoc54%
related🧫bEV-mediated synaptic pruning via C1q-C3 pathway54%
related🧫BDEV injection and recipient microglial transcriptome analys54%
related🧫Characterization of astrocyte-derived EVs and microglia upta54%
related🧫Sevoflurane-induced neurotoxicity (SIN) rat model54%
related🧫Microglia-specific SIRPα deletion in conditional knockout mi54%
related🧫Single-cell RNA sequencing analysis of microglial heterogene54%
related🧫Chi3l1 deletion effects on baseline glial activation in mice54%
related🧫Dexamethasone treatment study in α-synuclein mice54%
related🧫Small RNA profiling of neonatal astrocyte EVs and microglia 54%
related🧫Ex vivo IGF-I treatment in rd10 organotypic retinal explants54%
related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur54%
related🧫s:** - ALOX15 overexpression in healthy astrocytes should be54%
related🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional54%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr54%
related🧫s:** - Dose-response studies showing therapeutic window with54%
related🧫Morphological characterization of microglial states in human54%
related🧫Microglial SIRPα expression in human Alzheimer's diseas54%
related🧫Single-cell RNA sequencing of mouse brains54%
related🧫Microglial activation by bEVs via Piezo154%
related🧫Microglial depletion rescue experiment54%
related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal54%
related🧫4R-Tau Targeting Therapies for PSP and CBS54%
related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi54%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD54%
related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti54%
related🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?54%
related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy54%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri54%
related🧫ApoE4 Function in Alzheimer's Disease54%
related🧫Experiment: Autoimmune Hypothesis Testing in AD54%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring54%
related🧫Brainstem Circuit Modulation for PSP54%
related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi54%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise54%
related🧫Combination Therapy Sequencing in Parkinson's Disease54%
related🧫DLB Cognitive Fluctuation Mechanism Experiment54%
related🧫Genetic Risk Modifiers in DLB Phenotype54%
related🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras54%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i54%
related🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 54%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#54%
related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M54%
related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation54%
related🧫Gap Junction Dysfunction Validation in Parkinson's Dise54%
related🧫Iron Dyshomeostasis in MSA Pathogenesis Experiment54%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown54%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design54%
related🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise54%
related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr54%
related🧫Microglial Contributions to Huntington's Disease Pathog54%
related🧫Mixed Pathology Effects on Parkinson's Disease Progress54%
related🧫Neural Stem Cell Therapy for Alzheimer's Disease54%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise54%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper54%
related🧫Progranulin Replacement Therapy for FTD — Vector Development54%
related🧫PSP and CBS Biomarker Validation Study54%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson54%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise54%
related🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease54%
related🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#54%
related🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo54%
related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in54%
related🧫Traumatic Brain Injury and Alzheimer's Disease Relation54%
related🧫Experiment Validation: In vitro ThT Assay54%
related🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an54%
related🧫Tau ASO Therapy54%
related🧫Microglial TREM2 Agonist In Vivo Efficacy54%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim54%
related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia54%
mentions🧫QTJD effects on macrophage polarization and inflammatory res50%
mentions🧫CXCL10 biomarker analysis for CPSP prediction50%
mentions🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne50%
mentions🧫RBG treatment in ApoE-/- atherosclerosis mouse model50%
mentions🧫Leukocyte gene expression analysis in COVID-19 patients50%
mentions🧫P2RY12 inhibition in atherosclerosis mouse model50%
mentions🧫VSMC cholesterol efflux and P2RY12 signaling50%
mentions🧫P2RY12 regulation of autophagy in VSMCs50%
mentions🧫TLR expression in α-synuclein overexpressing mice50%
mentions🧫TLR expression analysis in Parkinson's disease patients50%
mentions🧫TLR4 Activation Assay with NETs and Anti-CarP Antibodies50%
mentions🧪Brain Insulin Resistance with Glucose Transporter Dysfunctio50%
mentions🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration50%
mentions🧪Selective HDAC3 Inhibition with Cognitive Enhancement50%
mentions🧪Ganglioside Rebalancing Therapy50%
mentions🧪CX43 hemichannel engineering enables size-selective mitochon50%
mentions🧪APOE Isoform Conversion Therapy50%
mentions🧪Astrocytic Connexin-43 Upregulation Enhances Neuroprotective50%
mentions🧪APOE-TREM2 Interaction Modulation50%
mentions🧪Arginine Methylation Enhancement Therapy50%
mentions🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu50%
mentions🧪Restoring Neuroprotective Tryptophan Metabolism via Targeted50%
mentions🧪RAB27A-dependent extracellular vesicle engineering for mitoc50%
mentions🧪Epigenetic Memory Reprogramming for Alzheimer's Disease50%
mentions🧪Age-Dependent Complement C4b Upregulation Drives Synaptic Vu50%
mentions🧪TREM2-Mediated Selective Aggregate Clearance Pathway50%
mentions🧪Targeted Butyrate Supplementation for Microglial Phenotype M50%
mentions🧪Adenosine-Astrocyte Metabolic Reset50%
mentions🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho50%
mentions🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors50%
mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%
mentions🧪LRP1-Dependent Tau Uptake Disruption50%
mentions🧪Cryptic Exon Silencing Restoration50%
mentions🧪APOE-Dependent Autophagy Restoration50%
mentions🧪Glycosaminoglycan Template Disruption Approach50%
mentions🧪Proteostasis Enhancement via APOE Chaperone Targeting50%
mentions🧪TREM2-Dependent Microglial Senescence Transition50%
mentions🧪Chaperone-Mediated APOE4 Refolding Enhancement50%
mentions🧪Context-Dependent CRISPR Activation in Specific Neuronal Sub50%
mentions🧪Sphingolipid Metabolism Reprogramming50%
mentions🧪Low Complexity Domain Cross-Linking Inhibition50%
mentions🧪Hypocretin-Neurogenesis Coupling Therapy50%
mentions🧪GAP43-mediated tunneling nanotube stabilization enhances neu50%
mentions🧪Synaptic Vesicle Tau Capture Inhibition50%
mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation50%
mentions🧪Perforant Path Presynaptic Terminal Protection Strategy50%
mentions🧪Axonal RNA Transport Reconstitution50%
mentions🧪Optogenetic Control of Mitochondrial Transfer Networks50%
mentions🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In50%
mentions🧪KDM6A-Mediated H3K27me3 Rejuvenation50%
mentions🧪Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro50%
mentions🧪Sleep Spindle-Synaptic Plasticity Enhancement50%
mentions🧪Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro50%
mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue50%
mentions🧪Pharmacological Enhancement of APOE4 Glycosylation50%
mentions🧪Gap Junction Hemichannel Modulation for Controlled Mitochond50%
mentions🧪Membrane Cholesterol Gradient Modulators50%
mentions🧪Flotillin-1 Stabilization Compounds50%
mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization50%
mentions🧪Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A50%
mentions🧪Complement-Mediated Synaptic Pruning Dysregulation50%
mentions🧪Temporal TET2-Mediated Hydroxymethylation Cycling50%
mentions🧪HDAC3-Selective Inhibition for Clock Reset50%
mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation50%
mentions🧪Transcriptional Autophagy-Lysosome Coupling50%
mentions🧪Digital Twin-Guided Metabolic Reprogramming50%
mentions🧪Lysosomal Positioning Dynamics Modulation50%
mentions🧪Lysosomal Enzyme Trafficking Correction50%
mentions🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai50%
mentions🧪Glial Glycocalyx Remodeling Therapy50%
mentions🧪Aquaporin-4 Polarization Rescue50%
mentions🧪HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor50%
mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
mentions🧪Reelin-Mediated Cytoskeletal Stabilization Protocol50%
mentions🧪HCN1-Mediated Resonance Frequency Stabilization Therapy50%
mentions🧪Transglutaminase-2 Cross-Linking Inhibition Strategy50%
mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%
mentions🧪Microglia-Derived Extracellular Vesicle Engineering for Targ50%
mentions🧪Mechanosensitive Ion Channel Reprogramming50%
mentions🧪Serine/Arginine-Rich Protein Kinase Modulation50%
mentions🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme50%
mentions🧪Multi-Modal CRISPR Platform for Simultaneous Editing and Mon50%
mentions🧪Vagal Afferent Microbial Signal Modulation50%
mentions🧪Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam50%
mentions🧪Near-infrared light therapy stimulates COX4-dependent mitoch50%
mentions🧪Sphingomyelin Synthase Activators for Raft Remodeling50%
mentions🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation50%
mentions🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli50%
mentions🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro50%
mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%
mentions🧪Circadian Clock-Autophagy Synchronization50%
mentions🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK50%
mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering50%
mentions🧪Senescent Microglia Resolution via Maresins-Senolytics Combi50%
mentions🔬Synaptic pruning by microglia in early AD50%
mentions🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem50%
mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬What are the mechanisms underlying mechanistic role of apoe 50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬How does metabolic reprogramming (glucose metabolism shifts,50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
related🔬Microglia activate astrocytes via IL-1alpha/TNF/C1q, and rea50%
related🔬Senolytics targeting p16/p21+ senescent astrocytes and micro50%
related🔬Synaptic pruning by microglia in early AD50%
mentions🧫Proposed experiment from debate on Synaptic pruning by micro40%
mentions🧫Proposed experiment from debate on Microglia activate astroc40%
mentions🧫Proposed experiment from debate on Senolytics targeting p16/40%
mentions🧫s:** - Compare brain penetration in FcRn+/+ vs FcRn-/- mice 40%
mentions🧫s:** - GPR32 knockout in microglia should worsen neuroinflam40%
mentions🧫Proposed experiment from debate on Synaptic pruning by micro40%
mentions🧫Proposed experiment from debate on Microglia activate astroc40%
mentions🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud40%
mentions🔬Microglia activate astrocytes via IL-1alpha/TNF/C1q, and rea40%
mentions🔬Senolytics targeting p16/p21+ senescent astrocytes and micro40%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
related🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration40%
related🧪Selective HDAC3 Inhibition with Cognitive Enhancement40%
related🧪Ganglioside Rebalancing Therapy40%
related🧪CX43 hemichannel engineering enables size-selective mitochon40%
related🧪Arginine Methylation Enhancement Therapy40%
related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu40%
related🧪RAB27A-dependent extracellular vesicle engineering for mitoc40%
related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi40%
related🧪Adenosine-Astrocyte Metabolic Reset40%
related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho40%
related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors40%
related🧪Nutrient-Sensing Epigenetic Circuit Reactivation40%
related🧪LRP1-Dependent Tau Uptake Disruption40%
related🧪Cryptic Exon Silencing Restoration40%
related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem40%
related🧪Chaperone-Mediated APOE4 Refolding Enhancement40%
related🧪Sphingolipid Metabolism Reprogramming40%
related🧪Low Complexity Domain Cross-Linking Inhibition40%
related🧪Hypocretin-Neurogenesis Coupling Therapy40%
related🧪GAP43-mediated tunneling nanotube stabilization enhances neu40%
related🧪Synaptic Vesicle Tau Capture Inhibition40%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation40%
related🧪Perforant Path Presynaptic Terminal Protection Strategy40%
related🧪Axonal RNA Transport Reconstitution40%
related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In40%
related🧪Synthetic Biology BBB Endothelial Cell Reprogramming40%
related🧪KDM6A-Mediated H3K27me3 Rejuvenation40%
related🧪Sleep Spindle-Synaptic Plasticity Enhancement40%
related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue40%
related🧪Pharmacological Enhancement of APOE4 Glycosylation40%
related🧪Membrane Cholesterol Gradient Modulators40%
related🧪Flotillin-1 Stabilization Compounds40%
related🧪Metabolic Switch Targeting for A1→A2 Repolarization40%
related🧪Temporal TET2-Mediated Hydroxymethylation Cycling40%
related🧪HDAC3-Selective Inhibition for Clock Reset40%
related🧪Chromatin Accessibility Restoration via BRD4 Modulation40%
related🧪Transcriptional Autophagy-Lysosome Coupling40%
related🧪Digital Twin-Guided Metabolic Reprogramming40%
related🧪Lysosomal Positioning Dynamics Modulation40%
related🧪Lysosomal Enzyme Trafficking Correction40%
related🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai40%
related🧪Glial Glycocalyx Remodeling Therapy40%
related🧪Aquaporin-4 Polarization Rescue40%
related🧪Competitive APOE4 Domain Stabilization Peptides40%
related🧪Reelin-Mediated Cytoskeletal Stabilization Protocol40%
related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy40%
related🧪TET2-Mediated Demethylation Rejuvenation Therapy40%
related🧪Mechanosensitive Ion Channel Reprogramming40%
related🧪Serine/Arginine-Rich Protein Kinase Modulation40%
related🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme40%
related🧪Vagal Afferent Microbial Signal Modulation40%
related🧪Near-infrared light therapy stimulates COX4-dependent mitoch40%
related🧪Sphingomyelin Synthase Activators for Raft Remodeling40%
related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia40%
related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation40%
related🧪Complement C1QA Spatial Gradient in Cortical Layers40%
related🧪APOE Isoform Expression Across Glial Subtypes40%
related🔬What are the mechanisms underlying selective vulnerability o39%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp39%
related🔬What are the mechanisms underlying tdp-43 phase separation t39%
mentions🔬What are the mechanisms underlying selective vulnerability o35%
mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp35%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t35%
mentions🔬What are the mechanisms underlying astrocyte reactivity subt35%
mentions🔬What are the mechanisms underlying blood-brain barrier trans35%
mentions🔬What are the mechanisms underlying apoe4 structural biology 35%
mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa35%
mentions🔬What are the mechanisms underlying digital biomarkers and ai35%
mentions🔬What are the mechanisms underlying senolytic therapy for age35%
mentions🔬What are the mechanisms underlying neuroinflammation resolut35%
mentions🔬What are the mechanisms underlying what are the mechanisms b35%
mentions🔬What are the mechanisms underlying what are the mechanisms b35%
mentions🔬What are the mechanisms underlying mitochondrial transfer be35%
mentions🔬What are the mechanisms underlying protein aggregation cross35%
mentions🔬What are the mechanisms underlying mechanistic role of apoe 35%
mentions🔬Investigate how lipid raft composition (cholesterol metaboli35%
mentions🔬What are the mechanisms underlying sleep disruption as cause35%
mentions🔬What are the mechanisms underlying rna binding protein dysre35%
mentions🔬What are the mechanisms underlying mitochondrial transfer be35%
mentions🔬What are the mechanisms underlying epigenetic clocks and bio35%
mentions🔬What are the mechanisms underlying perivascular spaces and g35%
mentions🔬Analyze circuit-level changes in neurodegeneration using All35%
mentions🔬What gene expression changes in the aging mouse brain predic35%
mentions🔬What gene expression changes in the aging mouse brain predic35%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di35%
mentions🔬Epigenetic reprogramming in aging neurons35%
mentions🔬Investigate prion-like spreading of tau pathology through co35%
mentions🔬How does metabolic reprogramming (glucose metabolism shifts,35%
mentions🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas35%
related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi35%
related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia35%
related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro35%